Genfit.fr

Categories: New newsletter subcribe

130Newsletters

0Subscriptions

Click here to subscribe to Genfit.fr

Newsletters

📃 [2019.02.27] GENFIT files Registrati on Statement for Proposed IPO in the US Genfit.fr
5 years ago
📃 [2019.02.04] GENFIT: Full -Year 2018 Financial Results Genfit.fr
5 years ago
📃 [2019.01.21] GENFIT: Financial Calendar for 2019 Genfit.fr
5 years ago
📃 [2019.01.03] GENFIT and LabCorp Si gn a Licensing Agreement to Expand Acce ss to an Innovative Diagnostic Assay f or Non-Alcoholic SteatoHepatitis (NASH) Genfit.fr
5 years ago
Season's Greetings from GENFIT! ⛄ GEN FIT vous présente ses Meilleursvœux ! Genfit.fr
6 years ago
📃 [2018.12.17] GENFIT: Positiv e 30-month DSMB Recommendation fo r Continuation of Phase 3 RESOLV E-IT Study of Elafibranor in NASH Genfit.fr
6 years ago
GENFIT: Positive Phase 2 Results from Study of Elafibranor in Primary Biliary Cholangitis | Rsultats positifs de ltude de Phase 2 valuant elafibranor dans la Cholangite Biliaire Primitive (PBC) Genfit.fr
6 years ago
GENFIT: Launch of a U.S. Phase 2 investigator-initiated study with nitazoxanide in patients with NASH-induced fibrosis | Lancement aux tats-Unis dune tude de Phase 2 initie par un investigateur, valuant nitazoxanide chez des patients avec fibrose NASH Genfit.fr
6 years ago
GENFIT announces plans to conduct registered public offering in the United States | GENFIT annonce son intention de procder une offre au public aux tats-Unis Genfit.fr
6 years ago
GENFIT: Third quarter 2018 financial information | GENFIT : information financire du troisime trimestre 2018 Genfit.fr
6 years ago
GENFIT: New data to be presented at 2018 AASLD meeting, ahead of key results expected in 2018 and 2019 | GENFIT : Nouvelles donnes prsentes lors du congrs de lAASLD 2018, en amont de rsultats cls attendus en 2018 et 2019 Genfit.fr
6 years ago
GENFIT: Further Details on Management Changes | GENFIT : prcisions sur lvolution organisationnelle annonce Genfit.fr
6 years ago
GENFIT : volution organisationnelle en vue dune anne 2019 charnire |GENFIT: Gearing Up for 2019 with Organizational Changes Genfit.fr
6 years ago
GENFIT : Rsultats Semestriels 2018 | GENFIT: 2018 H1 Results Genfit.fr
6 years ago
GENFIT : annonce sa participation plusieurs vnements financiers et ddis la NASH au cours des deux mois venir | GENFIT announces its upcoming participation in a number of investor and NASH-specific events over the next two months Genfit.fr
6 years ago
GENFIT : tape importante franchie avec la fin du recrutement des patients de lessai de Phase 2 valuant elafibranor dans la PBC | GENFIT: Major Milestone achieved with full recruitment of the Phase 2 trial evaluating elafibranor in PBC Genfit.fr
6 years ago
GENFIT : de nouvelles donnes prcliniques montrent quelafibranor empche le dveloppement de cancers lis la NAFLD/NASH | New Preclinical Data Shows Elafibranor Inhibits Development of NAFLD/NASH-Related Cancer Genfit.fr
6 years ago
GENFIT : Rsultats de l'Assemble Gnrale Ordinaire et Extraordinaire du 15 Juin 2018 | GENFIT: Outcome of the Ordinary and Extraordinary Shareholders' Meeting of June 15, 2018 Genfit.fr
6 years ago
GENFIT : annonce la nomination de Pascal Prigent au poste de Vice Prsident Excutif charg du Marketing et du Dveloppement Commercial | GENFIT: Announces the Nomination of Pascal Prigent as Executive Vice President Marketing and Commercial Development Genfit.fr
6 years ago
Meilleurs Voeux 2018 ! | Season's Greetings from GENFIT! Genfit.fr
7 years ago

© 2024